Back to top
more

Fidelity Select Biotechnology: (MF: FBIOX)

(MF) As of Oct 16, 2017 06:05 PM ET

 Add to portfolio

$231.43 USD

+0.08 (0.04%)

Zacks MF Rank 3-Hold     3    

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

View All Zacks Mutual Fund Rank #1's

Latest Performance as of Sep 30, 2017

Total Return %* Percentile Rank Objective
YTD 33.73 7
3 months 10.26 9
6 months 15.50 15
1 Year 21.30 13
3 Year 9.63 32
5 Year 20.25 8
10 Year 15.82 4

* Annual for three years and beyond.

Zacks Premium Research for FBIOX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank Hold 3
MF Research Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

%Unrealized Gain YTD 21.12
% Yield 0.00
% SEC Yield NA
Net Assets (Mil $) 9/30/2017 9,968.93
%Turnover 9/30/2017 28.00

Risk

3 Year 5 Year 10 Year
Beta 1.66 1.56 0.88
Alpha -4.03 0.99 10.82
R Squared 0.34 0.30 0.31
Std. Dev. 28.76 27.08 23.96
Sharpe 0.49 0.91 2.00

Sector / Country Weightings

As of 9/30/2017 % of Portfolio
Health 75.36
Services 12.26
Other 11.99
Industrial Cyclical 0.21
Energy 0.09
Finance 0.09

Portfolio Holdings

Top Equity Holdings
(As of 5/31/2017)
% of Portfolio Value (Mil$)
AMGEN INC 9.65 824.30
REGENERON PHARMACEUTICALS 6.46 551.86
CELGENE CORP 5.65 482.43
VERTEX PHARMACEUTICALS IN 4.16 355.47
ALEXION PHARMACEUTICALS I 3.91 334.09
BIOGEN INC 3.27 279.46
INCYTE PHARMACEUTICALS IN 2.57 219.30
BIOMARIN PHARMACEUTICAL 1.96 167.54
SEATTLE GENETICS INC 1.91 162.88

Stock Holding % of Net Assets

As Of 5/31/2017
Total Issues 216
Avg. P/E 32.68
Avg. P/Book 5.74
Avg. EPS Growth 15.5
Avg. Market Value (Mil $) 30,062

Allocation

% of Portfolio
Large Growth 20.38
Large Value 0.00
Small Growth 11.52
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 13.37
Foreign Bond 0.00
High Yield Bond 0.00